CREST syndrome is the combination of calcinosis, Raynaud’s phenomenon, esophageal
dysmotility, sclerodactyly, and telangiectasia.
Anticentromere antibodies are
reported in a high percentage of patients with CREST, but in
a small percentage of pure
scleroderma patients.